Award for buprenorphine/naloxone film base year with four one year options

Ended Indefinite Delivery Contract Awarded

Contract number
36E79720D0012
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order
IDV ceiling
$42,763,747.32
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs awarded a single-award indefinite delivery contract to DR Reddy's Laboratories, Inc. to supply an estimated 140,000 boxes annually of various strengths of Buprenorphine/Naloxone Film Sublingual. The contract has a one-year base period of performance beginning February 4, 2020 with four one-year option periods and a potential value of $42,763,747.32.

The original solicitation sought to establish a prime vendor contract to supply Buprenorphine/Naloxone Film Sublingual to the VA, DoD, BOP and IHS through their respective Pharmaceutical Prime Vendor programs. Offerors were required to provide pricing for the base year and all option periods, identify the exact drug name to appear on labels, and have a unique NDC number. The solicitation did not include any set-aside provisions and specified place of performance within the United States. Estimated annual requirements included over 6,500 boxes of the 12mg/3mg strength, 20,000 boxes of the 2mg/0.5mg strength, 6,700 boxes of the 4mg/1mg strength, and over 107,000 boxes of the 8mg/2mg strength.

The contract aims to establish an uninterrupted supply of Buprenorphine/Naloxone Film Sublingual, which is used to treat opioid addiction, for the VA and other federal agencies through their prime vendor networks. The single-award structure and option periods indicate the goal of procuring these pharmaceuticals in a cost-effective manner over multiple years from a single qualified source.

Transactions

Action Obligated Date
Terminate for Convenience P00001 · Termination for the government's convenience of buprenorphine/naloxone contract 36E79720D0012. Termination due to significant revision to the utilization… $0
Original award $0

Quick answers

Who was awarded contract 36E79720D0012?

36E79720D0012 was awarded to DR Reddy's Laboratories, Inc. by National Acquisition Center (Headquarters) on February 4, 2020.

How much is contract 36E79720D0012 worth?

36E79720D0012's own ceiling is $42,763,747.

Who can order from contract 36E79720D0012?

36E79720D0012 is a single award indefinite delivery contract.

Was contract 36E79720D0012 competed?

The extent of competition for 36E79720D0012 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV